MedPath

Comparison of the efficacy and tolerability of adapalene gel 0.1% versus tretinoin gel 0.05% in patients with mild to moderate acne vulgaris

Phase 2
Completed
Conditions
Acne vulgaris.
Acne vulgaris
Registration Number
IRCT201403109014N31
Lead Sponsor
Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
48
Inclusion Criteria

Any patient with mild to moderate acne vulgaris without limitation of age and gender.
Exclusion criteria: (a) Pregnancy or breast feeding; (b) using medication that have interaction with the drug under study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of the improvement of acne lesions. Timepoint: at zero time and then at 4th and 12th weeks after treatment. Method of measurement: based on the Global Acne Grading System with comparison of the photos taken from the location of the lesions.
Secondary Outcome Measures
NameTimeMethod
ocal dry skin. Timepoint: at 4th and 12th weeks after treatment. Method of measurement: through physical examination.;Local erythema. Timepoint: at 4th and 12th weeks after treatment. Method of measurement: through clinical examination.;Local skin irritation. Timepoint: at 4th and 12th weeks after treatment. Method of measurement: through taking history of the patient.
© Copyright 2025. All Rights Reserved by MedPath